This retrospective observational cohort study was conducted at the Department of Obstetrics and Gynecology, Van Training and Research Hospital, a tertiary referral center in eastern Türkiye. The study period spanned from January 2020 to June 2023. The study included patients who underwent total hysterectomy for benign gynecological indications using one of the three conventional surgical approaches routinely performed at our institution during the study period: total abdominal hysterectomy, total laparoscopic hysterectomy, or total vaginal hysterectomy. Robotic-assisted hysterectomy was not routinely performed at our center during the study period and was therefore not included in the analysis. The study was reported in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines.
The study included women aged 18–75 years who underwent total hysterectomy for benign gynecological indications during the study period. Surgical approach was determined in routine clinical practice according to surgical indication, uterine size, pelvic anatomy, presence of prolapse, previous surgery, comorbidities, surgeon judgment, and institutional practice, rather than by random allocation. Patients were excluded if they had incomplete demographic or clinical records, inadequate compliance with clinical examination, missing sexual function assessment data, or insufficient perioperative documentation for the outcomes of interest. Patients undergoing hysterectomy for malignant indications, obstetric indications, or emergency life-threatening hemorrhage were not included. After application of these criteria, 466 patients were included in the final analysis.
Patient-level data included demographic characteristics age, height, weight, body mass index, gravida, parity, comorbidities, and history of previous surgery; surgical variables including indication score, uterine size, operative time, and type of hysterectomy; and clinical outcomes including preoperative and postoperative hemoglobin and hematocrit levels, blood transfusion requirement, postoperative complications, vaginal length, and sexual function scores. Estimated intraoperative blood loss was not consistently recorded in the retrospective surgical records and therefore could not be included as a study variable or incorporated into the transfusion models.
Postoperative complications were defined as any adverse medical or surgical event occurring within 30 days after hysterectomy, including bleeding requiring reoperation; wound-related complications such as infection, hematoma, or dehiscence; febrile morbidity defined as a body temperature ≥38°C on two or more consecutive postoperative days excluding the first 24 hours; urinary tract infection or urinary tract injury confirmed by laboratory, imaging, or operative findings; and readmission or reintervention related to postoperative events. Minor and self-limiting conditions such as transient nausea, mild ileus, or short-term fever were not classified as complications.
The primary outcome was the change in vaginal length from preoperative to postoperative assessment. Secondary outcomes included postoperative female sexual function assessed by the Female Sexual Function Index (FSFI), male partner sexual function assessed by the International Index of Erectile Function-5 (IIEF-5), postoperative complication rates, and blood transfusion requirement. Analyses of male partner sexual function were considered exploratory because partner data were available for a subset of 297 cases. Analyses involving partner outcomes were restricted to these patients, and missing partner data were excluded by listwise deletion.
Clinical and perioperative data were extracted retrospectively from electronic hospital records. Operative time was defined as the interval from skin incision to completion of the surgical procedure. All hysterectomies were performed by gynecologic surgeons at a tertiary referral center according to standard institutional surgical practice. The choice of surgical route was based on clinical indication, pelvic anatomy, uterine size when available, presence of prolapse, previous surgical history, comorbidities, and surgeon judgment.
Vaginal length was measured intraoperatively using a hysterometer immediately before hysterectomy and at the completion of the procedure, ensuring a standardized assessment across surgical techniques. Hemoglobin and hematocrit levels were obtained from routine laboratory tests performed preoperatively and during the early postoperative period as part of standard clinical care. Estimated intraoperative blood loss was not consistently documented in the electronic surgical records and therefore could not be analyzed.
Female and male sexual function were evaluated using validated instruments, namely the Female Sexual Function Index and the International Index of Erectile Function-5, respectively [ 11 , 12 ], based on documented preoperative and postoperative assessments recorded in patient files. Postoperative sexual function assessments were conducted at routine follow-up visits, typically around 8 weeks after surgery, with an acceptable window of 6–12 weeks. When multiple postoperative assessments were available, the measurement closest to 8 weeks was used for analysis. Therefore, sexual function outcomes in this study should be interpreted as early postoperative functional assessments rather than long-term sexual function outcomes.
The study data were accessed for research purposes between 01/05/2023 and 15/06/2023 in accordance with institutional regulations.
The final sample size reflected all eligible patients who met the inclusion criteria during the study period. No a priori sample size calculation was performed because of the retrospective design. Therefore, the analyses were exploratory and based on the available cohort.
The study protocol was approved by the Non-Interventional Clinical Research Ethics Committee of Van Regional Training and Research Hospital approval date: 26/04/2023; protocol no: 2023/09–04. The study was conducted in accordance with the Declaration of Helsinki. Due to the retrospective design and the use of de-identified routinely collected clinical data, the requirement for informed consent was waived by the ethics committee. The minimal anonymized dataset underlying this study is restricted due to patient privacy and institutional regulations. Qualified researchers may request access to the data by contacting the Non-Interventional Clinical Research Ethics Committee of Van Regional Training and Research Hospital (Contact Email:
[email protected], Phone: + 90 432 222 00 10). The study data were accessed and extracted for research purposes after ethics approval, between 01/05/2023 and 15/06/2023, in accordance with institutional regulations. Clinical trial registration was not applicable because this was a retrospective observational study.
Statistical analyses were performed using IBM SPSS Statistics version 20.0 IBM Corp., Armonk, NY, USA. The distribution of continuous variables was assessed visually using histograms and Q–Q plots and analytically using the Kolmogorov–Smirnov test. Continuous variables were summarized as mean ± standard deviation or median interquartile range, as appropriate, while categorical variables were presented as number and percentage.
Comparisons among surgical groups were performed using one-way analysis of variance with Tukey’s post-hoc test for normally distributed continuous variables. Paired sample t-tests were used for within-group preoperative and postoperative comparisons. Categorical variables were compared using Pearson’s chi-square test or Fisher’s exact test, as appropriate.
Multivariable analyses included linear regression models for postoperative vaginal length and postoperative FSFI scores, and binary logistic regression models for postoperative complications and blood transfusion requirement. Candidate variables were selected based on clinical relevance and availability in the retrospective database. For postoperative vaginal length, the model included preoperative vaginal length, surgical type, age, body mass index, uterine size, and operative time. For postoperative FSFI score, the model included preoperative FSFI score, surgical type, age, body mass index, and postoperative complications. For blood transfusion, the model included operative time, preoperative hemoglobin, and preoperative hematocrit. For postoperative complications, the model included age, body mass index, operative time, and uterine size.
Because preoperative hemoglobin and hematocrit are biologically related parameters, multicollinearity was assessed using variance inflation factors before interpretation of the transfusion model. Estimated intraoperative blood loss could not be included in the transfusion model because it was not consistently available in the retrospective surgical records. Uterine size was included in models when available; missing uterine size data were not imputed. Analyses involving male partner IIEF-5 scores were restricted to patients with available partner data and were considered exploratory.
Model diagnostics included assessment of multicollinearity using variance inflation factors, goodness-of-fit using Nagelkerke R² for logistic regression models, and calibration using the Hosmer–Lemeshow test. All analyses were exploratory in nature. A two-sided p-value <0.05 was considered statistically significant, without adjustment for multiple comparisons.